Medical Perspectives on Autism Spectrum Disorders

Ronald L. Lindsay

doi:10.1055/s-2005-922441

Seminars in Hearing, Table of Contents

Semin Hear 2005; 26(4): 191-201
DOI: 10.1055/s-2005-922441

Medical Perspectives on Autism Spectrum Disorders

Ronald L. Lindsay¹

¹Director of Research, Arizona Child Study Center, Developmental and Behavioral Pediatrics, Children's Health Center of St. Joseph's Hospital and Medical Center; Associate Professor of Clinical Pediatrics, University of Arizona Health Science Center, Tucson, Arizona

Abstract

ABSTRACTS

This article provides a general overview of the current diagnostic criteria and methodology for identifying children with autism. It addresses an apparent increase in the prevalence of autism and potential contributing factors to this increase. A discussion on therapeutic modalities available for the treatment of autism is offered. The roles of pediatricians and the care of children with autistic spectrum disorders, as part of an interdisciplinary team, are highlighted.

KEYWORDS

Autism spectrum disorders - Asperger disorder - applied behavioral analysis

Full Text

References

REFERENCES

1 Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943; 2 217-250
2 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington, DC; APA 1980
3 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC; APA 1986
4 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC; APA 1994
5 Yeargin-Alsopp M, Reiss C, Karapurkar T et al.. Prevalence of autism in a US metropolitan area. JAMA. 2003; 289 49-55
6 Bertrand J, Mars A, Boyle C et al.. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics. 2001; 108 1155-1161
7 Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA. 2001; 285 3093-3099
8 Barbaresi W R, Katusic S K, Collagen R C et al.. Explaining the apparent increase in the incidence of autism in Olmstead County Minnesota from 1976 to 1997. J Dev Behav Pediatr. 2002; 23 398-399
9 Barton M, Volkmar F. How commonly are known medical conditions associated with autism?. J Autism Dev Disord. 1998; 28 273-278
10 Bailey A, Luthert P, Dean A et al.. A clinicopathological study of autism. Brain. 1998; 121 889-905
11 Kemper T L, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol. 1998; 57 645-652
12 Nelson K B, Grether J K, Crien L A et al.. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol. 2001; 49 597-606
13 Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT. Br J Psychiatry. 1992; 161 839-843
14 Siegel B. Pervasive Developmental Disorders Screening Test-II. San Antonio, TX; Harcourt Publishing 2004
15 Robins D L, Fein D, Barton M L, Green J A. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord. 2001; 31(2) 131-144
16 Schopler E, Reichler R, Renner B R. The Childhood Autism Rating Scale (CARS). Austin, TX; Pro-Ed 1988
17 Gilliam J E. Gilliam Autism Rating Scale (GARS). Austin, TX; Pro-Ed 1995
18 Rutter M, Le Couteur A, Lord C. ADI-R Autism Diagnostic Interview-Revised. Los Angeles, CA; Western Psychological Services 2003
19 Lord C, Rutter M L, Goode S et al.. Autism Diagnostic Observation Schedule: A standardized observation of communicative and social behavior. J Autism Dev Disord. 1989; 19(2) 185-212
20 Lovaas O I. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol. 1997; 55 3-9
21 Wieder S, Greenspan S I. Climbing the symbolic ladder in the DIR model through floor time/interactive play. Autism. 2003; 7(4) 425-435
22 Aman M G, Van Bourgondien M E, Wolford P L, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. J Am Acad Child Adolec Psychiatry. 1995; 34 1672-1681
23 Langworthy-Lam K S, Aman M G, Van Bourgondien M E. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. J Child Adolesc Psychiatry. 2002; 12 311-321
24 Research Units on Pediatric Psychopharmacology Autism Network . Risperidone in children with autism and serious behavioral disturbances. N Engl J Med. 2002; 347 314-321
25 McDougale C J, Naylor S T, Cohen C J et al.. A double-blind, placebo-controlled study all flew Fox a mean in adults with autistic disorder. Arch Gen Psychiatry. 1996; 53 1001-1008
26 American Academy of Pediatrics .Complementary and alternative medicine. Available at: http://www.aap.org/visit/tfocam.htm Accessed October 14, 2005
27 Aman M G, Singh N N. Vitamin, mineral, in dietary treatment. In: Aman MG, Singh NN Psychopharmacology of the Developmental Disabilities. New York; Springer-Verlag 1998: 168-196
28 Kleijnen J, Knipschild P. Niacin and vitamin B-6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry. 1991; 29 931-941
29 Tolbert L, Haigler T, Waits M M, Dennis T. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord. 1993; 23 193-199
30 Findling R L, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Witznitzer M. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutatory effects in a double-blind placebo-controlled study. J Autism Dev Disord. 1997; 27 467-478
31 Knivsberg A M, Reichelt K L, Hoien T, Nodland M. A randomized, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2002; 5 251-261
32 Sponheim E. Gluten-free diet in infantile autism: a therapeutic trial. Tidsskrift for Den Norske Laegeforening. 1991; 111 704-707
33 Wakefield A J, Murch S H, Anthony A et al.. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and perseverative developmental disorder in children. Lancet. 1998; 351 637-641
34 Murch S H, Anthony A, Casson D H et al.. Retraction of an interpretation. Lancet. 2004; 363(9411) 750
35 Stratton K. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington, DC; National Academy Press 2001
36 Lord C. Is secretin a useful treatment in autism?. J Autism Devel Disord. 1999; 29 269

Ronald L LindsayM.D.

3600 N. 3rd Ave.

Phoenix, AZ 85013

Email: rlindsay@chw.edu